RecruitingCorEvitas International Adolescent Atopic Dermatitis (AD) Drug Safety and Effectiveness RegistryProspective observational registry for an adolescent cohort with AD under the care of a dermatology provider. Approximately 1500 subjects and 75 clinical sites in North America and select European countries will be recruited to participate with no defined upper limit for either target.